期刊文献+

血清多项肿瘤标志物联合检测在肺癌诊断中的价值 被引量:16

Clinical significance of multiple serum tumor markers combined detection in the diagnosis of lung cancer
暂未订购
导出
摘要 目的探讨癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)联合检测在肺癌诊断中的临床价值。方法采用化学发光法对61例肺癌患者和38例肺部良性病变患者血清CEA、CYFRA21-1、NSE水平进行检测。根据接受者工作特性曲线(ROC),确定最佳截断点及诊断灵敏度、特异度。结果肺癌组患者血清CEA、CYFRA21-1、NSE水平均明显高于肺部良性病变组,差异有统计学意义(P<0.05);3项肿瘤标志物在不同病理类型肺癌中的水平差异无统计学意义(P>0.05);CEA诊断肺癌最佳截断点为3.50ng/mL,灵敏度和特异度分别为52.5%、94.7%;CYFRA21-1最佳截断点为5.21ng/mL,灵敏度和特异度分别为67.2%、93.1%;NSE最佳截断点为18.09ng/mL,灵敏度和特异度分别为77.0%、52.6%。3项指标联合检测的灵敏度为96.7%,高于3项单独检测时的灵敏度(P<0.05)。结论检测CEA、CYFRA21-1和NSE对肺癌的诊断有一定价值,3者联合检测有明显的互补性,可提高肺癌诊断的灵敏度。 Objective To study the clinical significance of Carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CY- FRA21-1) ,neuron specific enolization enzyme (NSE) combined detection in the diagnosis of lung cancer. Methods Using the Chemiluminescence to detect the level of CEA,NSE and CYFRA21-1 in 61 patient with lung cancer(lung cancer group) and 38 pa- tients with benign diseases(control group). All datas were analyzed with t test. Optimal cut-off point and diagnostic sensitivity, spe- cificity were obtained by receiver operating characteristic curve(ROC). Results The level of serum CEA,NSE and CYFRA21-1 in Lung cancer group was significantly higher than that in control group(P〈0.05). The expression level of three tumor markers was no statistically significant difference in the different pathological types of lung cancer(P〉0.05). The cut-off point of CEA was 3.50 ng/mL, sensitivity and speciality were 52.5 %, 94.7 % respectively. The cut-off point of CYFRA21-1 was 5.21 ng/mL, the sensitiv- ity and specificity were 67.2% ,93.1%. The cut-off of point NSE was 18.09 ng/mL, the sensitivity and specificity were 77.0%, 52.60//00. The three combined detection sensitivity was 96.7%, significantly higher than separate one(P〈0.05). Conclusion The three tumor markers(CEA,CYFRA21-1 ,NSE) might be valuable in the diagnosis of lung cancer. The combined detection could be used as a better pattern for screening lung cancer.
作者 敖素华 杨峰
出处 《重庆医学》 CAS CSCD 北大核心 2013年第31期3764-3765,共2页 Chongqing medicine
关键词 肺肿瘤 肿瘤标志物 癌胚抗原 细胞角蛋白19片段 神经元特异性烯醇化酶 lung neoplasms tumor markers carcinoembryonic antigen cytokeratin 19 fragment neuron-specific enolase
  • 相关文献

参考文献10

二级参考文献63

共引文献154

同被引文献99

  • 1丁湘彧,张宝秋,张洁,王雪玉,尹颜军,荣长利,时广利.肺癌患者血清中肿瘤标志物检测的临床意义[J].中华临床医师杂志(电子版),2011,5(16):4646-4650. 被引量:35
  • 2吕晓涓,黄海波,董震.不同病理类型老年肺癌患者外周血血清肿瘤标志物表达差异[J].中国老年学杂志,2014,34(7):1971-1972. 被引量:14
  • 3Mie M,Kai T,Le T,et al.Selection of DNA aptamers with affinity for pro-gastrin-releasing peptide(pro GRP),a tumor marker for small cell lung cancer[J].Appl Biochem Biotechnol,2013,16(1):250-255
  • 4Devriese LA,Bosma JHM.Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis[J].Lung cancer,2012,29(2):467-471
  • 5Patel JL,Erickson J A, Roberts WL, et al. Performance character istics of anautomated assay for the quantitation of CYFRA 21-1 in human serum[J]. Clin Biochem,2010,43(18) : 1449-1452.
  • 6Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21- 1 in non-small cell lung Cancer[J]. Anticancer Res, 2010,30 (7): 3099-3102.
  • 7Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors [J]. J NatlCancer Inst, 2000,92 (3) : 205-216.
  • 8Shu J, Li CG, Liu YC, et al. Comparison of serum tumor associated material (TAM) with conventional biomarkers in Cancer patients [J]. Asian Pae J Cancer Prev,2012,13(5) :2399 -2403.
  • 9Zaieska M, Szturmowicz M, Zych J, et al. Elevated serum NSE lev el in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival[J]. Pneumonol Alergol Pol,2010,78(1) :14 -20.
  • 10邢爱民,刘淑芹,李立宇.肺癌患者血清肿瘤标志物联合检测的临床意义[J].疑难病杂志,2010,9(1):22-24. 被引量:9

引证文献16

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部